Genetics of hypertension, target-organ complications, and response to therapy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.CIR.102.SUPPL_4.IV-40PMID 11080130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Familial hypercholesterolemia

  2011cited by this paper
• THE METABOLIC AND MOLECULAR BASES OF INHERITED DISEASE

  2010cited by this paper
• Das Herz bei arterieller Hypertonie

  2006cited by this paper
• Lack of association of the angiotensinogen‐6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program

  2000cited by this paper
• Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension.

  2000cited by this paper
• Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.

  2000cited by this paper
• Essential hypertension. Part I: definition and etiology.

  2000cited by this paper
• Are there differences among angiotensin receptor blockers?

  1999cited by this paper
• Shattuck lecture--medical and societal consequences of the Human Genome Project.

  1999cited by this paper
• Evaluation of markers on human chromosome 10, including the homologue of the rodent Rf-1 gene, for linkage to ESRD in black patients.

  1999cited by this paper
• How will knowledge of the human genome affect drug therapy

  1999cited by this paper
• Field of needs: the genetics of stroke.

  1999cited by this paper
• Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis

  1999cited by this paper
• Comparative antihypertensive effects of angiotensin II receptor antagonists.

  1999cited by this paper
• How will knowledge of the human genome affect drug therapy?

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Evaluation of genetic risk factors for silent brain infarction.

  1999cited by this paper
• Computational genomics: the medicine of the future?

  1999cited by this paper
• The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study.

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Genetic initiation of hypertensive and diabetic nephropathy.

  1998cited by this paper
• Adducin in essential hypertension

  1998cited by this paper
• Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks.

  1998cited by this paper
• The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2 adrenoceptors.

  1998cited by this paper
• Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension.

  1998cited by this paper
• Genomics in the real world.

  1998cited by this paper
• Pharmacogenomics: a new approach to individual therapy of hypertension?

  1998cited by this paper
• Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation.

  1998cited by this paper
• Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.

  1997cited by this paper
• Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension

  1997cited by this paper
• Notch3 Mutations in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a Mendelian Condition Causing Stroke and Vascular Dementia

  1997cited by this paper
• A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.

  1997cited by this paper
• Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction.

  1997cited by this paper
• A pharmacogenetic approach to blood pressure in Lyon hypertensive rats. A chromosome 2 locus influences the response to a calcium antagonist.

  1997cited by this paper
• Variations on a Theme: Cataloging Human DNA Sequence Variation

  1997cited by this paper
• Millennium exploits retained right with new venture

  1997cited by this paper
• Phase II results in rheumatoid arthritis encouraging for Immunex

  1997cited by this paper
• Heritability of left ventricular mass: the Framingham Heart Study.

  1997cited by this paper
• Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.

  1997cited by this paper
• Molecular Genetics of Human Blood Pressure Variation

  1996cited by this paper
• Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.

  1996cited by this paper
• Hypertension and stroke

  1996cited by this paper
• The Use of Genetic Information in Large-scale Clinical Trials: Applications to Alzheimer Research

  1996cited by this paper
• From UBOs to Binswanger's disease. Impact of magnetic resonance imaging on vascular dementia research.

  1996cited by this paper
• Blood pressure and end-stage renal disease in men.

  1996cited by this paper
• Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans.

  1996cited by this paper
• Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat

  1996cited by this paper
• Positional cloning moves from perditional to traditional

  1995cited by this paper
• Response to a Second Single Antihypertensive Agent Used as Monotherapy for Hypertension After Failure of the Initial Drug

  1995cited by this paper
• Renal failure among male Hispanics in the United States.

  1995cited by this paper
• Do we need more anti-hypertensive drugs: lessons from the new biology.

  1995cited by this paper
• Familial risk, age at onset, and cause of end-stage renal disease in white Americans.

  1995cited by this paper
• Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.

  1995cited by this paper
• Choosing the right ACE inhibitor. A guide to selection.

  1995cited by this paper
• Linkage of the angiotensinogen gene to essential hypertension.

  1994cited by this paper
• Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations.

  1994cited by this paper
• Hypertension: Pathophysiology, Diagnosis, and Management

  1994cited by this paper
• How many genes in the human genome?

  1994cited by this paper
• Evaluation of organ damage in hypertension.

  1993cited by this paper
• M235T variant of the human angiotensinogen gene in unselected hypertensive patients

  1993cited by this paper
• Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo

  1993cited by this paper
• Small artery structure in hypertension. Dual processes of remodeling and growth.

  1993cited by this paper
• Positional cloning: Let's not call it reverse anymore

  1992cited by this paper
• Molecular basis of human hypertension: role of angiotensinogen.

  1992cited by this paper
• Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample.

  1991cited by this paper
• Metabolic Abnormalities of Hypertension A Lesson in Complexity

  1991cited by this paper
• Blood pressure control--special role of the kidneys and body fluids.

  1991cited by this paper
• Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

  1991cited by this paper
• The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group.

  1991cited by this paper
• Familial aggregation and genetic epidemiology of blood pressure

  1990cited by this paper
• Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins.

  1990cited by this paper
• 1989 Corcoran Lecture: Adaptive and Maladaptive Responses of the Arterial Wall to Hypertension

  1990cited by this paper
• Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.

  1986cited by this paper
• Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins.

  1985cited by this paper
• Comparison of acebutolol and propranolol in essential hypertension.

  1985cited by this paper
• Hypertension and stroke.

  1984cited by this paper
• Correlation of pharmacological effects with plasma levels of antihypertensive drugs in man.

  1979cited by this paper
• Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension

  1976cited by this paper

• A IMPORTÂNCIA DOS MÉTODOS DE IMAGEM NO DIAGNÓSTICO DIFERENCIAL DE CARDIOPATIA HIPERTENSIVA E CARDIOMIOPATIA HIPERTRÓFICA: RELATO DE CASO

  2021cites this paper
• Frequence Des Complications De L’hypertension Arterielle Chez Les Patients Suivis En Milieu Cardiologique A Parakou En 2016

  2020cites this paper
• Epidemiology of Peripheral Artery Disease of Lower Limbs among Workers toCotonou in 2013

  2017cites this paper
• Deficient prolylcarboxypeptidase gene and protein expression in left ventricles of spontaneously hypertensive rats (SHR).

  2014cites this paper
• The Genetics of Blood Pressure and Body Mass Index: The Tale of Two Major Risk Factors.

  2013cites this paper
• Shared Genetic Effects among Measures of Cognitive Function and Leukoaraiosis

  2012cites this paper
• Particularités et modalités de la prise en charge de l’hypertension artérielle dans les pays d’Afrique subsaharienne

  2011cites this paper
• Variants in Genes Involved in Functional Pathways Associated with Hypertension in African Americans

  2010cites this paper
• Cardiopatia hipertensiva: aspectos epidemiológicos, prevalência e fator de risco cardiovascular Hypertensive cardiopathy: epidemiological aspects, prevalence and cardiovascular risk factors

  2008cites this paper
• Regressão da hipertrofia ventricular esquerda e a terapia anti-hipertensiva Regression of the left ventricular hypertrophy and the anti-hypertensive therapy

  2008cites this paper
• The pressure of finding human hypertension genes: new tools, old dilemmas

  2008cites this paper
• Influencia de los antecedentes familiares sobre la edad de aparición de la hipertensión. Implicación de la impronta genética

  2008cites this paper
• The Role of Myocardial Collagen Network in Hypertensive Heart Disease

  2007cites this paper
• Fixed-Dose Combination Antihypertensives and Reduction in Target Organ Damage

  2007cites this paper
• Variability in response to cardiovascular drugs.

  2006cites this paper
• β2‐Adrenergic receptor polymorphisms and treatment‐induced regression of left ventricular hypertrophy in hypertension

  2006cites this paper
• New directions in the assessment and treatment of hypertensive heart disease

  2005cites this paper
• Genomics-Based Tools and Technology

  2005cites this paper
• Genomic Susceptibility Loci for Brain Atrophy in Hypertensive Sibships From the GENOA Study

  2005cites this paper
• Genes That Modify Susceptibility to Atherosclerosis: Targets for Drug Action

  2004cites this paper
• Cardiovascular Pharmacogenetics

  2004cites this paper
• The Genetic Basis of Essential Hypertension and Its Implications for Treatment

  2004cites this paper
• Genetic discoveries and nursing implications for complex disease prevention and management.

  2004cites this paper
• The Glu27 allele of the β2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension

  2004cites this paper
• Heritability of Leukoaraiosis in Hypertensive Sibships

  2004cites this paper
• Peroxisome Proliferator–Activated Receptor-&ggr; Coactivator-1 Gene Locus: Associations with Hypertension in Middle-Aged Men

  2003cites this paper
• Pharmacogenomics of primary hypertension--the lessons from the past to look toward the future.

  2003cites this paper
• Diagnosis and Treatment of Primary Hypertension Series

  2003cites this paper
• Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects

  2002cites this paper
• Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension.

  2002cites this paper
• Autonomic effects of vasoactive drugs: physiological insights and clinical implications

  2002cites this paper
• Diuretic Therapy, the α-Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension

  2002cites this paper
• Influência de fatores ambientais e genéticos na hipertrofia e remodelamento cardíacos na hipertensão arterial

  2001cites this paper
• Clinical aspects of hypertensive myocardial fibrosis

  2001cites this paper
• HEDEF ORGAN KOMPLİKASYONSUZ ESANSİYEL HİPERTANSİYONDA ENDOTEL VE VASKÜLER FONKSİYON BOZUKLUĞU

  2001cites this paper
• Effects of Antihypertensive Agents on the Left Ventricle

  2001cites this paper